Industry News
Pharmaceutical Industry News
In $2.6B cancer deal, Seagen bets China’s first homemade ADC can challenge Roche, AZ-Daiichi
In $2.6B cancer deal, Seagen bets China's first homemade ADC can challenge Roche, AZ-Daiichi aliu Mon, 08/09/2021 - 10:24
Roche snags coveted Polivy win in newly diagnosed lymphoma. But is it enough to change 2 decades of established treatment practices?
Roche snags coveted Polivy win in newly diagnosed lymphoma. But is it enough to change 2 decades of established treatment practices? aliu Mon, 08/09/2021 - 08:14
AstraZeneca, Daiichi Sankyo build Enhertu’s blockbuster case with breast cancer win against Roche’s Kadcyla
AstraZeneca, Daiichi Sankyo build Enhertu's blockbuster case with breast cancer win against Roche's Kadcyla aliu Mon, 08/09/2021 - 05:53
Michael Pollan’s ‘Trip Report’
The author discusses his psychedelic journey and why the government embraces some drugs while waging a war against others.
Sanofi notches another Pompe win with FDA blessing for enzyme replacement therapy Nexviazyme
Sanofi notches another Pompe win with FDA blessing for enzyme replacement therapy Nexviazyme fkansteiner Fri, 08/06/2021 - 14:44
From vaccine halo to liability? Reputation tracker says COVID-19 shot makers now dinged for safety, supply issues
From vaccine halo to liability? Reputation tracker says COVID-19 shot makers now dinged for safety, supply issues bbulik Fri, 08/06/2021 - 14:24
Gilead cracks down on fake versions of popular HIV drugs Biktarvy, Descovy being sold at US pharmacies
Gilead cracks down on fake versions of popular HIV drugs Biktarvy, Descovy being sold at US pharmacies aliu Fri, 08/06/2021 - 11:06
Sanofi and Regeneron solidify Dupixent TV ad lead, topping July pharma spenders again, trailed by AbbVie and Novo Nordisk
Sanofi and Regeneron solidify Dupixent TV ad lead, topping July pharma spenders again, trailed by AbbVie and Novo Nordisk bbulik Fri, 08/06/2021 - 10:34
Sanofi and Regeneron solidify Dupixent TV ad lead in July, trailed by AbbVie and Novo Nordisk
Sanofi and Regeneron solidify Dupixent TV ad lead in July, trailed by AbbVie and Novo Nordisk bbulik Fri, 08/06/2021 - 10:34
GSK again scores $235M in ‘skinny label’ case, but court admits it’s ‘unclear what Teva even did wrong’
GSK again scores $235M in 'skinny label' case, but court admits it's 'unclear what Teva even did wrong' kdunleavy Fri, 08/06/2021 - 09:59
Spectrum’s Rolontis, angling to rival Amgen’s Neulasta, hit with FDA rejection over manufacturing ‘deficiencies’
Spectrum's Rolontis, angling to rival Amgen's Neulasta, hit with FDA rejection over manufacturing 'deficiencies' fkansteiner Fri, 08/06/2021 - 09:40
AstraZeneca chief Soriot lends GlaxoSmithKline’s Walmsley CEO wisdom, support as activist investors press for change
AstraZeneca chief Soriot lends GlaxoSmithKline's Walmsley CEO wisdom, support as activist investors press for change aliu Fri, 08/06/2021 - 09:25
While Novo’s GLP-1 meds post big gains, the company is still looking to create an insulin ‘revolution,’ CEO says
While Novo's GLP-1 meds post big gains, the company is still looking to create an insulin 'revolution,' CEO says fkansteiner Fri, 08/06/2021 - 08:32
Gilead Foundation bounces back with a bang—$200M in the bank and ambitious goals
Gilead Foundation bounces back with a bang—$200M in the bank and ambitious goals bbulik Fri, 08/06/2021 - 07:59
Fierce Pharma Asia—BeiGene’s flagship U.S. hub, Brukinsa win; Takeda’s tax bill, regulatory delays
Fierce Pharma Asia—BeiGene's flagship U.S. hub, Brukinsa win; Takeda's tax bill, regulatory delays aliu Fri, 08/06/2021 - 06:14
Sanofi, Regeneron stop Libtayo-chemo lung cancer trial early on strong survival data
Sanofi, Regeneron stop Libtayo-chemo lung cancer trial early on strong survival data fkansteiner Thu, 08/05/2021 - 11:36
Regeneron’s COVID-19 antibodies rake in $2.6B, reflecting their market dominance and blowing away estimates
Regeneron's COVID-19 antibodies rake in $2.6B, reflecting their market dominance and blowing away estimates kdunleavy Thu, 08/05/2021 - 11:18
‘The kidney medicine’: Bayer touts Kerendia’s blockbuster potential as its pharma group swings back to growth
'The kidney medicine': Bayer touts Kerendia's blockbuster potential as its pharma group swings back to growth aliu Thu, 08/05/2021 - 10:22
Moderna, citing variants and waning immunity, expects COVID-19 boosters to become a fact of life
Moderna, citing variants and waning immunity, expects COVID-19 boosters to become a fact of life esagonowsky Thu, 08/05/2021 - 10:03
Pfizer, Flynn face revived U.K. antitrust accusations of ‘unfairly high’ prices on epilepsy drug
Pfizer, Flynn face revived U.K. antitrust accusations of 'unfairly high' prices on epilepsy drug aliu Thu, 08/05/2021 - 07:25